Intraperitoneal chemotherapy: Hot, timely, and relevant?

The use of hyperthermic intraperitoneal chemotherapy has been growing in popularity in recent years. Even with a positive randomized trial, issues concerning the study design and the statistical analysis raise questions about whether this technique should be recommended as a standard‐of‐care approach. There are many questions that remain unanswered.